These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38321884)

  • 41. Preclinical activity of cobimetinib alone or in combination with chemotherapy and targeted therapies in renal cell carcinoma.
    Zhang L; Xie D; Lei Y; Na A; Zhu L
    Future Oncol; 2021 Aug; 17(23):3051-3060. PubMed ID: 33906367
    [No Abstract]   [Full Text] [Related]  

  • 42. Indirect co-culture of lung carcinoma cells with hyperthermia-treated mesenchymal stem cells influences tumor spheroid growth in a collagen-based 3-dimensional microfluidic model.
    Dhiman N; Shagaghi N; Bhave M; Sumer H; Kingshott P; Rath SN
    Cytotherapy; 2021 Jan; 23(1):25-36. PubMed ID: 32771259
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Targeting renal cell carcinoma with NVP-BEZ235, a dual PI3K/mTOR inhibitor, in combination with sorafenib.
    Roulin D; Waselle L; Dormond-Meuwly A; Dufour M; Demartines N; Dormond O
    Mol Cancer; 2011 Jul; 10():90. PubMed ID: 21791089
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HIF2α is involved in the expansion of CXCR4-positive cancer stem-like cells in renal cell carcinoma.
    Micucci C; Matacchione G; Valli D; Orciari S; Catalano A
    Br J Cancer; 2015 Oct; 113(8):1178-85. PubMed ID: 26439684
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Functional significance of CD105-positive cells in papillary renal cell carcinoma.
    Matak D; Brodaczewska KK; Szczylik C; Koch I; Myszczyszyn A; Lipiec M; Lewicki S; Szymanski L; Zdanowski R; Czarnecka AM
    BMC Cancer; 2017 Jan; 17(1):21. PubMed ID: 28056882
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Stemness and anti-cancer drug resistance in ATP-binding cassette subfamily G member 2 highly expressed pancreatic cancer is induced in 3D culture conditions.
    Sasaki N; Ishiwata T; Hasegawa F; Michishita M; Kawai H; Matsuda Y; Arai T; Ishikawa N; Aida J; Takubo K; Toyoda M
    Cancer Sci; 2018 Apr; 109(4):1135-1146. PubMed ID: 29444383
    [TBL] [Abstract][Full Text] [Related]  

  • 47. FOXC1 induces cancer stem cell-like properties through upregulation of beta-catenin in NSCLC.
    Cao S; Wang Z; Gao X; He W; Cai Y; Chen H; Xu R
    J Exp Clin Cancer Res; 2018 Sep; 37(1):220. PubMed ID: 30189871
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Comparison of efficacy between sorafenib and sunitinib as first-line therapy for metastatic renal cell carcinoma and analyze prognostic factors for survival].
    Cai W; Yuan YC; Li MY; Kong W; Dong BJ; Chen YH; Zhang J; Xue W; Huang YR; Zhou LX; Huang JW
    Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):384-389. PubMed ID: 29860767
    [No Abstract]   [Full Text] [Related]  

  • 49. Microdevices for cancer stem cell culture as a predictive chemotherapeutic response platform.
    Agüero EI; Belgorosky D; García-Silva JI; Booth R; Lerner B; Pérez MS; Eiján AM
    J Mol Med (Berl); 2023 Nov; 101(11):1465-1475. PubMed ID: 37755493
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Partial acquisition of stemness properties in tumorspheres obtained from interleukin-8-treated MCF-7 cells.
    Ospina-Muñoz N; Vernot JP
    Tumour Biol; 2020 Dec; 42(12):1010428320979438. PubMed ID: 33325322
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Zoledronic acid inhibits the growth of cancer stem cell derived from cervical cancer cell by attenuating their stemness phenotype and inducing apoptosis and cell cycle arrest through the Erk1/2 and Akt pathways.
    Wang L; Liu Y; Zhou Y; Wang J; Tu L; Sun Z; Wang X; Luo F
    J Exp Clin Cancer Res; 2019 Feb; 38(1):93. PubMed ID: 30791957
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Spheres derived from the human SN12C renal cell carcinoma cell line are enriched in tumor initiating cells.
    Zhang Y; Sun B; Zhao X; Sun H; Cui W; Liu Z; Yao X; Dong X
    J Exp Clin Cancer Res; 2016 Oct; 35(1):163. PubMed ID: 27756344
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Galectin-3 promotes CXCR2 to augment the stem-like property of renal cell carcinoma.
    Huang CS; Tang SJ; Lee MH; Chang Wang CC; Sun GH; Sun KH
    J Cell Mol Med; 2018 Dec; 22(12):5909-5918. PubMed ID: 30246456
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Endoglin Is Essential for the Maintenance of Self-Renewal and Chemoresistance in Renal Cancer Stem Cells.
    Hu J; Guan W; Liu P; Dai J; Tang K; Xiao H; Qian Y; Sharrow AC; Ye Z; Wu L; Xu H
    Stem Cell Reports; 2017 Aug; 9(2):464-477. PubMed ID: 28793246
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Enrichment and characterization of cancer stem‑like cells from a cervical cancer cell line.
    Wang L; Guo H; Lin C; Yang L; Wang X
    Mol Med Rep; 2014 Jun; 9(6):2117-23. PubMed ID: 24676900
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reciprocal activation between STAT3 and miR-181b regulates the proliferation of esophageal cancer stem-like cells via the CYLD pathway.
    Xu DD; Zhou PJ; Wang Y; Zhang L; Fu WY; Ruan BB; Xu HP; Hu CZ; Tian L; Qin JH; Wang S; Wang X; Li YC; Liu QY; Ren Z; Zhang R; Wang YF
    Mol Cancer; 2016 May; 15(1):40. PubMed ID: 27189061
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Wnt5a-mediating neurogenesis of human adipose tissue-derived stem cells in a 3D microfluidic cell culture system.
    Choi J; Kim S; Jung J; Lim Y; Kang K; Park S; Kang S
    Biomaterials; 2011 Oct; 32(29):7013-22. PubMed ID: 21705075
    [TBL] [Abstract][Full Text] [Related]  

  • 58. NGAL can alternately mediate sunitinib resistance in renal cell carcinoma.
    Yu DS; Wu CL; Ping SY; Huang YL; Shen KH
    J Urol; 2014 Aug; 192(2):559-66. PubMed ID: 24423438
    [TBL] [Abstract][Full Text] [Related]  

  • 59. YM155 reverses rapamycin resistance in renal cancer by decreasing survivin.
    Koike H; Nitta T; Sekine Y; Arai S; Furuya Y; Nomura M; Matsui H; Shibata Y; Ito K; Oyama T; Suzuki K
    J Cancer Res Clin Oncol; 2014 Oct; 140(10):1705-13. PubMed ID: 24916171
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Galangin sensitizes TRAIL-induced apoptosis through down-regulation of anti-apoptotic proteins in renal carcinoma Caki cells.
    Han MA; Lee DH; Woo SM; Seo BR; Min KJ; Kim S; Park JW; Kim SH; Choi YH; Kwon TK
    Sci Rep; 2016 Jan; 6():18642. PubMed ID: 26725939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.